Major finding: CRAF has a direct role in mitosis that does not require the RAF effector MEK.

Mechanism: CRAF interacts with PLK1 and promotes its activity and accumulation at kinetochores.

Impact: Allosteric RAF inhibitors that block phospho-Ser338 CRAF may be effective cancer therapies.

This content is only available via PDF.